cisapride has been researched along with Emesis in 18 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although combination antiemetics prevent vomiting during the initial 24 h after high-dose (> or =100 mg/m2) cisplatin, many patients experience delayed emesis 24-120 h afterwards despite receiving prophylactic dexamethasone and metoclopramide during this time." | 9.09 | Oral cisapride for the control of delayed vomiting following high-dose cisplatin. ( Baltzer, L; Grant, SC; Hinckley, L; Kris, MG; Miller, VA; Pisters, KM; Pizzo, BA, 1999) |
| "Cisapride was previously used in the same indication." | 6.74 | Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study. ( Advani, N; Alatas, S; Firmansyah, A; Hegar, B; Vandenplas, Y, 2009) |
| "Cisapride is a strong prokinetic gastrointestinal drug that could have a role in the prevention of DE." | 6.70 | Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration. ( Caristi, N; Maisano, R; Pergolizzi, S; Salimbeni, V; Spadaro, P; Toscano, G, 2001) |
| "Treatment with cisapride 10 mg, 4 times daily improved her condition, and this was associated with improved small intestinal motility during a 12-hour examination using a computer aided system." | 5.28 | Cisapride stimulates small intestinal motility and relieves constipation in myelopathy due to cervical spinal stenosis: case report. ( Aly, A; Hellström, PM; Johansson, C, 1990) |
| "Although combination antiemetics prevent vomiting during the initial 24 h after high-dose (> or =100 mg/m2) cisplatin, many patients experience delayed emesis 24-120 h afterwards despite receiving prophylactic dexamethasone and metoclopramide during this time." | 5.09 | Oral cisapride for the control of delayed vomiting following high-dose cisplatin. ( Baltzer, L; Grant, SC; Hinckley, L; Kris, MG; Miller, VA; Pisters, KM; Pizzo, BA, 1999) |
| " We present single-subject trials of two pediatric patients done to assess the effect of cisapride on symptoms arising from gastroesophageal reflux." | 5.07 | The single-subject randomized trial. A useful clinical tool for assessing therapeutic efficacy in pediatric practice. ( Issenman, RM; Langer, JC; Winthrop, AL, 1993) |
| "Cisapride was previously used in the same indication." | 2.74 | Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study. ( Advani, N; Alatas, S; Firmansyah, A; Hegar, B; Vandenplas, Y, 2009) |
| "Cisapride is a strong prokinetic gastrointestinal drug that could have a role in the prevention of DE." | 2.70 | Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration. ( Caristi, N; Maisano, R; Pergolizzi, S; Salimbeni, V; Spadaro, P; Toscano, G, 2001) |
| "Recurrent vomiting is one of many functional conditions for which it is difficult to find an explanation and to treat." | 1.33 | A case report on a patient suffering from recurrent vomiting episodes, whose condition improved markedly during pregnancy and breast feeding. ( Ohlsson, B, 2006) |
| "Vomiting was the first cause of admission in diabetics." | 1.29 | Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin. ( Gallar, P; Guijo, G; Oliet, A; Ortega, O; Vigil, A, 1993) |
| "Cisapride was a potent stimulant of gastric emptying in rats, 7 times more potent than metoclopramide." | 1.28 | General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride. ( Awouters, FH; Megens, AA; Niemegeers, CJ, 1991) |
| "Treatment with cisapride 10 mg, 4 times daily improved her condition, and this was associated with improved small intestinal motility during a 12-hour examination using a computer aided system." | 1.28 | Cisapride stimulates small intestinal motility and relieves constipation in myelopathy due to cervical spinal stenosis: case report. ( Aly, A; Hellström, PM; Johansson, C, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 11 (61.11) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, DP | 1 |
| Flynn, DL | 1 |
| Shone, RL | 1 |
| Gullikson, G | 1 |
| Hegar, B | 1 |
| Alatas, S | 1 |
| Advani, N | 1 |
| Firmansyah, A | 1 |
| Vandenplas, Y | 1 |
| Ohlsson, B | 1 |
| Washabau, RJ | 1 |
| Hall, JA | 1 |
| Carella, G | 1 |
| Marra, L | 1 |
| Langer, JC | 1 |
| Winthrop, AL | 1 |
| Issenman, RM | 1 |
| Gallar, P | 1 |
| Oliet, A | 1 |
| Vigil, A | 1 |
| Ortega, O | 1 |
| Guijo, G | 1 |
| Sood, AK | 1 |
| Malhotra, RC | 1 |
| Sood, S | 1 |
| Güller, R | 1 |
| Reichlin, B | 1 |
| Jost, G | 1 |
| Pizzo, BA | 1 |
| Pisters, KM | 1 |
| Miller, VA | 1 |
| Grant, SC | 1 |
| Baltzer, L | 1 |
| Hinckley, L | 1 |
| Kris, MG | 1 |
| Mukhopadhyay, K | 1 |
| Narang, A | 1 |
| Kumar, P | 1 |
| Chakraborty, S | 1 |
| Mittal, BR | 1 |
| Maisano, R | 1 |
| Spadaro, P | 1 |
| Toscano, G | 1 |
| Caristi, N | 1 |
| Pergolizzi, S | 1 |
| Salimbeni, V | 1 |
| Shinawi, M | 1 |
| Brik, R | 1 |
| Berkowitz, D | 1 |
| Jenkins, HR | 1 |
| Verrier-Jones, K | 1 |
| Megens, AA | 1 |
| Awouters, FH | 1 |
| Niemegeers, CJ | 1 |
| Hellström, PM | 1 |
| Aly, A | 1 |
| Johansson, C | 1 |
| McCallum, RW | 1 |
1 review available for cisapride and Emesis
| Article | Year |
|---|---|
Cisapride.
Topics: Animals; Cisapride; Esophagus; Gastric Emptying; Gastroesophageal Reflux; Gastrointestinal Motility; | 1995 |
5 trials available for cisapride and Emesis
| Article | Year |
|---|---|
Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study.
Topics: Antiemetics; Cardiovascular System; Cisapride; Domperidone; Electrocardiography; Esophageal pH Monit | 2009 |
The single-subject randomized trial. A useful clinical tool for assessing therapeutic efficacy in pediatric practice.
Topics: Adult; Child; Child, Preschool; Cisapride; Gagging; Gastroesophageal Reflux; Humans; Infant; Male; P | 1993 |
[Colonic preparation with sodium phosphate. Prospective, randomized, placebo-controlled double blind study with various antiemetics].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Cathartics; Cisapride | 1996 |
Oral cisapride for the control of delayed vomiting following high-dose cisplatin.
Topics: Abdominal Pain; Administration, Oral; Aged; Antiemetics; Antineoplastic Agents; Cisapride; Cisplatin | 1999 |
Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Cisapride; Cisplatin; Dexamet | 2001 |
12 other studies available for cisapride and Emesis
| Article | Year |
|---|---|
Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750.
Topics: Adamantane; Animals; Aza Compounds; Benzamides; Cisplatin; Dogs; Gastrointestinal Agents; Gastrointe | 2004 |
[With evidence-based phytotherapy. Takes away gastric and intestinal irritation].
Topics: Antiemetics; Cisapride; Clinical Trials as Topic; Dopamine Antagonists; Evidence-Based Medicine; Gas | 2003 |
A case report on a patient suffering from recurrent vomiting episodes, whose condition improved markedly during pregnancy and breast feeding.
Topics: Acetylcholine; Adult; Breast Feeding; Cisapride; Endoscopy, Digestive System; Female; Gastric Emptyi | 2006 |
[Prokinetic drugs in digestive disorders].
Topics: Antineoplastic Agents; Cisapride; Domperidone; Esophageal Motility Disorders; Gastroesophageal Reflu | 1993 |
Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin.
Topics: Cisapride; Diabetes Mellitus, Type 1; Erythromycin; Female; Gastric Emptying; Hospitalization; Human | 1993 |
Rumination-treatment with cisapride.
Topics: Adolescent; Adult; Cisapride; Female; Gastroesophageal Reflux; Humans; Male; Parasympatholytics; Pip | 1995 |
Gastroesophageal reflux and pulmonary complication in a neonate.
Topics: Antiemetics; Apnea; Cisapride; Follow-Up Studies; Gastroesophageal Reflux; Gastrointestinal Agents; | 1998 |
Gastrointestinal tract cytomegalovirus infection with prolonged vomiting and fever in an immunocompetent child.
Topics: Cisapride; Cytomegalovirus; Cytomegalovirus Infections; Fever; Gastrointestinal Agents; Gastrointest | 2001 |
Vomiting and chronic renal failure.
Topics: Administration, Oral; Cisapride; Gastroesophageal Reflux; Humans; Infant; Kidney Failure, Chronic; P | 1991 |
General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.
Topics: Animals; Apomorphine; Bethanechol Compounds; Cisapride; Conditioning, Operant; Diarrhea; Dogs; Gastr | 1991 |
Cisapride stimulates small intestinal motility and relieves constipation in myelopathy due to cervical spinal stenosis: case report.
Topics: Cisapride; Constipation; Female; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Intest | 1990 |
Review of the current status of prokinetic agents in gastroenterology.
Topics: Benzamides; Chemical Phenomena; Chemistry; Cisapride; Dexamethasone; Digestive System; Domperidone; | 1985 |